INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 147 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $123,000 | -65.2% | 35,000 | 0.0% | 0.01% | -44.4% |
| Q3 2018 | $353,000 | +11.4% | 35,000 | -20.1% | 0.01% | +12.5% |
| Q2 2018 | $317,000 | +42.8% | 43,830 | +19.4% | 0.01% | +14.3% |
| Q1 2018 | $222,000 | -33.1% | 36,700 | +6.4% | 0.01% | -22.2% |
| Q4 2017 | $332,000 | -24.4% | 34,500 | -30.3% | 0.01% | -43.8% |
| Q3 2017 | $439,000 | -22.0% | 49,500 | +11.2% | 0.02% | -33.3% |
| Q2 2017 | $563,000 | +19.0% | 44,500 | -1.1% | 0.02% | +26.3% |
| Q1 2017 | $473,000 | +145.1% | 45,000 | +114.3% | 0.02% | +111.1% |
| Q4 2016 | $193,000 | -22.2% | 21,000 | 0.0% | 0.01% | -40.0% |
| Q3 2016 | $248,000 | -10.8% | 21,000 | -2.4% | 0.02% | -31.8% |
| Q2 2016 | $278,000 | -42.1% | 21,510 | -28.3% | 0.02% | +4.8% |
| Q1 2016 | $480,000 | -44.1% | 30,000 | 0.0% | 0.02% | -64.4% |
| Q4 2015 | $859,000 | -13.8% | 30,000 | -14.3% | 0.06% | +34.1% |
| Q3 2015 | $996,000 | -53.8% | 35,000 | -41.7% | 0.04% | -48.2% |
| Q2 2015 | $2,155,000 | -17.6% | 60,000 | +33.3% | 0.08% | -26.7% |
| Q1 2015 | $2,616,000 | +41.0% | 45,000 | +2.3% | 0.12% | +81.2% |
| Q4 2014 | $1,855,000 | +36.7% | 44,000 | +25.7% | 0.06% | +93.9% |
| Q3 2014 | $1,357,000 | +44.8% | 35,000 | +16.7% | 0.03% | +65.0% |
| Q2 2014 | $937,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |